Annis Gardner Whiting Capital Advisors’s Biogen BIIB Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Buy	5,233 +41	+0.8%	+$7.84K	0.17%	105
2026 Q1	$952K	Buy	5,192 +2	+0%	+$369	0.15%	117
2025 Q4	$913K	Buy	5,190 +12	+0.2%	+$1.96K	0.17%	108
2025 Q3	$725K	Buy	5,178 +369	+8%	+$49.9K	0.15%	116
2025 Q2	$604K	Buy	4,809 +396	+9%	+$49.3K	0.21%	102
2025 Q1	$604K	Buy	4,413 +4	+0.1%	+$572	0.26%	82
2024 Q4	$674K	Sell	4,409 -27	-0.6%	-$4.55K	0.19%	101
2024 Q3	$860K	Sell	4,436 -595	-12%	-$124K	0.24%	80
2024 Q2	$1.17M	Buy	5,031 +4,241	+537%	+$922K	0.33%	52
2024 Q1	$170K	Buy	790 +767	+3,335%	+$180K	0.06%	206
2023 Q4	$5.95K	Hold	23	–	–	﹤0.01%	526
2023 Q3	$5.91K	Buy	+23	New	+$6.15K	﹤0.01%	512

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's BIIB Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors increased its Biogen (BIIB) stake by 0.79% in Q2 2026, buying an estimated $7.84K and bringing the position to 5,233 shares worth $1.13M. The position accounts for 0.17% of the portfolio, ranked #105.

Annis Gardner Whiting Capital Advisors first reported a position in BIIB in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.17M in Q2 2024. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Annis Gardner Whiting Capital Advisors held 5,233 shares of Biogen worth $1.13M as of Q2 2026.
Annis Gardner Whiting Capital Advisors bought 41 Biogen shares in Q2 2026, an estimated $7.84K.
Biogen made up 0.17% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #105 holding.
Annis Gardner Whiting Capital Advisors first reported a position in Biogen in Q3 2023 and has held it in 12 quarters since.
Annis Gardner Whiting Capital Advisors's Biogen position peaked at $1.17M in Q2 2024.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.